AdAlta $0.024
(0.00%)
|
High $0.03 |
Low $0.02 |
Trades 24 |
Turnover $54,432 |
Volume 2,170,184 |
| 30 June 2023 at 3:59pm | ||||
ADALTA LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $8,030,422 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
Company Presentation
1AD released this announcement to the ASX on 25 July 2022, 8:24. The announcement is not marked as price sensitive, and is 23 page(s) in length and 4.11MB in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Company Presentation | 25 July 2022, 8:24 |
| Quarterly Appendix 4C and Activities Report | 25 July 2022, 8:17 |
| Notification regarding unquoted securities - 1AD | 6 July 2022, 8:23 |
| Notification of cessation of securities - 1AD | 5 July 2022, 9:48 |
If you were already registered, log in here.
If you were already registered, log in here.